Early research (Phase 1)Ended earlyNCT03064854
What this trial is testing
PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients
Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 111